- Home
- YMM vs ASND Comparison
YMM vs ASND Comparison
Compare YMM & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMM
- ASND
- Stock Information
- Founded
- YMM 2011
- ASND 2006
- Country
- YMM China
- ASND Denmark
- Employees
- YMM N/A
- ASND N/A
- Industry
- YMM Computer Software: Prepackaged Software
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- YMM Technology
- ASND Health Care
- Exchange
- YMM Nasdaq
- ASND Nasdaq
- Market Cap
- YMM 12.3B
- ASND 12.0B
- IPO Year
- YMM 2021
- ASND 2015
- Fundamental
- Price
- YMM $12.33
- ASND $208.78
- Analyst Decision
- YMM Buy
- ASND Strong Buy
- Analyst Count
- YMM 3
- ASND 16
- Target Price
- YMM $13.00
- ASND $244.19
- AVG Volume (30 Days)
- YMM 7.2M
- ASND 446.2K
- Earning Date
- YMM 11-19-2025
- ASND 11-13-2025
- Dividend Yield
- YMM 1.55%
- ASND N/A
- EPS Growth
- YMM 64.18
- ASND N/A
- EPS
- YMM 0.55
- ASND N/A
- Revenue
- YMM $1,695,281,415.00
- ASND $576,332,355.00
- Revenue This Year
- YMM $6.27
- ASND $102.31
- Revenue Next Year
- YMM $6.98
- ASND $76.44
- P/E Ratio
- YMM $21.43
- ASND N/A
- Revenue Growth
- YMM 25.14
- ASND 54.50
- 52 Week Low
- YMM $8.20
- ASND $118.03
- 52 Week High
- YMM $14.07
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- YMM 43.24
- ASND 59.58
- Support Level
- YMM $11.66
- ASND $187.25
- Resistance Level
- YMM $14.07
- ASND $214.76
- Average True Range (ATR)
- YMM 0.45
- ASND 5.93
- MACD
- YMM -0.18
- ASND 1.02
- Stochastic Oscillator
- YMM 27.53
- ASND 78.27
About YMM Full Truck Alliance Co. Ltd. (each representing 20)
Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.